CAVALIERE, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 968
EU - Europa 800
AS - Asia 579
SA - Sud America 81
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 16
OC - Oceania 1
Totale 2.468
Nazione #
US - Stati Uniti d'America 938
RU - Federazione Russa 357
SG - Singapore 211
CN - Cina 191
IT - Italia 108
DE - Germania 64
BR - Brasile 60
VN - Vietnam 59
IE - Irlanda 54
SE - Svezia 48
HK - Hong Kong 45
FR - Francia 43
GB - Regno Unito 37
FI - Finlandia 27
CA - Canada 21
IN - India 18
KR - Corea 16
NL - Olanda 11
ZA - Sudafrica 11
AR - Argentina 8
ES - Italia 8
BD - Bangladesh 7
BE - Belgio 7
UA - Ucraina 7
AT - Austria 6
ID - Indonesia 6
PL - Polonia 6
EC - Ecuador 5
JP - Giappone 4
TR - Turchia 4
CL - Cile 3
IQ - Iraq 3
LT - Lituania 3
PE - Perù 3
PK - Pakistan 3
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
JO - Giordania 2
NI - Nicaragua 2
PR - Porto Rico 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
GI - Gibilterra 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.446
Città #
Ashburn 171
Moscow 138
Chandler 113
Dallas 112
Singapore 110
San Jose 78
Dublin 51
Hong Kong 45
Verona 42
Beijing 30
Munich 30
Council Bluffs 26
The Dalles 26
Hanoi 19
Ann Arbor 18
Ho Chi Minh City 18
New York 18
Helsinki 17
Jacksonville 17
Jinan 16
Los Angeles 14
Lawrence 13
Princeton 13
Sindelfingen 12
Santa Clara 11
Southend 11
Atlanta 10
Taiyuan 10
Wilmington 10
Frankfurt am Main 9
Johannesburg 9
Tianjin 9
Turku 9
London 8
Redondo Beach 8
São Paulo 8
Brussels 7
Columbus 7
Guangzhou 7
Phoenix 7
Washington 7
Buffalo 6
Chennai 6
Milan 6
Barnet 5
Denver 5
Haikou 5
Monza 5
Redmond 5
Stockholm 5
Toronto 5
Zhengzhou 5
Changsha 4
Jakarta 4
Madrid 4
Nuremberg 4
Orem 4
Poplar 4
Rio de Janeiro 4
San Francisco 4
Shenyang 4
Tokyo 4
Warsaw 4
Brasília 3
Buenos Aires 3
Chicago 3
Dongguan 3
Fuzhou 3
Hebei 3
Montreal 3
New Delhi 3
Seattle 3
Taizhou 3
Amman 2
Amsterdam 2
Bari 2
Bengaluru 2
Birmingham 2
Brescia 2
Calgary 2
Cao Lanh 2
Castro Valley 2
Cleveland 2
Da Nang 2
Dearborn 2
Des Moines 2
Dhaka 2
Fairfield 2
Falkenstein 2
Fortaleza 2
Honolulu 2
Houston 2
Hải Dương 2
Jackson 2
Kyiv 2
Lahore 2
Lanzhou 2
Lima 2
Managua 2
Manchester 2
Totale 1.480
Nome #
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 269
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 216
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 208
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 197
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 194
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 185
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 181
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 173
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 170
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 169
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 164
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 126
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 114
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 90
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 12
Totale 2.468
Categoria #
all - tutte 9.569
article - articoli 9.569
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202268 0 0 0 0 2 2 2 6 5 4 15 32
2022/2023317 15 39 22 48 19 87 0 29 47 5 5 1
2023/2024178 6 9 17 26 13 38 24 12 1 11 17 4
2024/2025373 12 21 18 58 16 14 19 24 44 25 45 77
2025/20261.159 73 55 112 187 291 95 93 60 92 70 15 16
2026/2027171 9 22 51 83 6 0 0 0 0 0 0 0
Totale 2.468